RSS

BCAP Baron Capital Enterprise, INC.

Last Post: 09/12/24
Followers: 102
Posts Today: 0
Views Today: 518

BCAP Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Sep 23, 9:30 AM EDT
Last0.0000
$ Chg0.0000
Open—
High—
Beta-222.2700
Year High0.000
Market Cap3.7K
P/B Ratio—
EPS—
Avg Vol (30d)88.6K
Volume0
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low0.000
Total Shares—
Shares Out3.69B
Float3.69B
ExchangeOTCID
Finance Credit Finance

BCAP Stock Message Board Discussion

  1. acc724

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 214

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 0

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 10

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 164

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Cookie Storage Solution Enhances Baking Experience

Updated Category News Views 311

Innovative Cookie Storage & Cooling Solution In the realm of baking, having the right tools can make all the difference, especially when it comes to cooling and storing cookies. An inventive individual from New Kent faced frustrations while trying to manage space during the festive baking period. Realizing the need for a solution, this inventor developed the SHERIS COOKIE...

Continue Reading
Alarum Technologies Securities Class Action Update and Analysis

Updated Category News Views 122

Understanding Alarum Technologies Securities Class Action Investors of Alarum Technologies Ltd. (NASDAQ: ALAR) may be facing a significant turning point regarding their investments. A class action lawsuit has been initiated concerning the actions of the company during a specified period. Those affected during this critical time frame have important rights and potential...

Continue Reading
TransCode Therapeutics Schedules Adjourned Special Meeting Updates

Updated Category News Views 211

TransCode Therapeutics Provides Updates on Adjourned Special Meeting TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has announced the adjournment of its Special Meeting, originally scheduled to gather shareholder votes on critical proposals. The meeting will now take place virtually on May 2, allowing shareholders to participate in a flexible and accessible format. The delay...

Continue Reading
Understanding Rep. Mike Kelly's Recent Union Pacific Stock Trading

Updated Category News Views 219

Understanding Rep. Mike Kelly's Recent Stock Activity Recently filed disclosures reveal that Representative Mike Kelly took part in a noteworthy transaction involving Union Pacific, valued between $15,001 and $50,000. This filing was made on December 12, 2024, highlighting the ongoing stock activities of congressional members. As of now, the share price for Union Pacific...

Continue Reading
Cohen & Steers Fund Details: Distribution and Returns Overview

Updated Category News Views 84

Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) stirred the pot back in 2024 when it laid out its managed distribution policy to bolster returns and maintain shareholder interest. The monthly distributions, set at a fixed rate per common share, aimed to give investors a reliable income stream while capitalizing on various investment opportunities throughout the...

Continue Reading